Abstract

Previous studies in the experimental animal on hepatosplenic schistosomiasis mansoni after antischistosomal treatment have revealed marked regression of both overt disease and liver lesions; treatment in all instances was instituted at the acute or early chronic stage of the disease. In the present study treatment was started in the late chronic stages of hepatosplenic schistosomiasis: regression of the disease was relatively slight over a 25-week period.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.